Incidence and course of Kawasaki disease in Mexico

被引:0
|
作者
Sotelo Cruz, Norberto [1 ]
机构
[1] Univ Sonora, Hosp Infantil Estado Sonora, Serv Clin Pediat, Hermosillo 19600, Sonora, Mexico
来源
SALUD I CIENCIA | 2011年 / 18卷 / 02期
关键词
Kawasaki disease; vasculitis; coronary aneurysms; acquired heart disease;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Kawasaki disease (KD) affects children aged 1 to 5 years. It manifests with fever and vasculitis in various organs and damage to the coronary arteries in the heart occur. Objective: To analyze KD after reviewing what was published in Mexico from 1977 to 2010. Material and methods: Based on the published material on KD, diagnostic clinical findings, cardiac disorders, laboratory analyses and imaging, complications, treatment disease course and mortality, as well as descriptive statistics were used. Results: In 155 cases, patient ages ranged from 3 to 5 years, the proportion of males vs females was 3.3:1; coronary aneurysms were found by echocardiography in 61 children (39%), myocarditis in 19 (12%), pericardial effusion in 9 (5.8%), aortic insufficiency in 4, mitral regurgitation in 5, the most common laboratory findings were leucocytosis, neutrophilia, thrombocytosis, elevation of ESR and C-reactive protein level. Forty-two patients were treated with aspirin, 104 (67%) received gamma globulin and aspirin, 30 (19%) dipyridamole, and prednisone and methylprednisolone were used in less than 3% of the patients. Three months after their discharge from hospital, 124 children (80%) had no sequelae, 11 had giant aneurysms, and 8 myocardial infarction, 3 had bypass surgery, 3 died (1.9%). Conclusions: In Mexico, the early use of gamma globulin and aspirin resulted in a decrease of coronary lesions due to Kawasaki disease.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 50 条
  • [21] The incidence of Kawasaki disease using hospital admissions data for England 2006-2021
    Odingo, Myron
    Rutter, Megan
    Bowley, Jonathan
    Peach, Emily J.
    Lanyon, Peter C.
    Grainge, Matthew J.
    Stillwell, Peter
    McPhail, Sean
    Bythell, Mary
    Aston, Jeanette
    Stevens, Sarah
    McCormack, Rachael
    Brogan, Paul
    Pearce, Fiona A.
    RHEUMATOLOGY, 2023, 62 (09) : 3117 - 3125
  • [22] Clinical characteristics and course of patients with Kawasaki disease at a general hospital
    Geli, Guadalupe
    Eymann, Alfredo
    Perez, Lucia
    De Cunto, Carmen
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2022,
  • [23] Association of respiratory infections with the incidence and treatment efficacy in Kawasaki disease
    Hachisuka, Soshi
    Kitano, Taito
    Kitagawa, Daisuke
    Murata, Masayuki
    Onishi, Mai
    Mori, Takahiro
    Okubo, Tenshin
    Yamamoto, Naohiro
    Nishikawa, Hiroki
    Onaka, Masayuki
    Suzuki, Rika
    Sekine, Madoka
    Suzuki, Soma
    Nakamura, Fumihiko
    Yoshida, Sayaka
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (03)
  • [24] INCIDENCE AND CLINICAL-FEATURES OF INCOMPLETE KAWASAKI-DISEASE
    FUKUSHIGE, J
    TAKAHASHI, N
    UEDA, Y
    UEDA, K
    ACTA PAEDIATRICA, 1994, 83 (10) : 1057 - 1060
  • [25] Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
    Yu, Hun-Ju
    Chuang, Meng-Ni
    Chu, Chiao-Lun
    Wu, Pei-Lin
    Ho, Shu-Chen
    Kuo, Ho-Chang
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [26] Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain
    Sanchez-Manubens, J.
    Anton, J.
    Bou, R.
    Iglesias, E.
    Calzada-Hernandez, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : S139 - S144
  • [27] An update on Kawasaki disease
    Cimaz, R
    Falcini, F
    AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 258 - 263
  • [28] Kawasaki Disease update
    Jane C. Burns
    The Indian Journal of Pediatrics, 2009, 76 : 71 - 76
  • [29] Kawasaki Disease update
    Burns, Jane C.
    INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (01) : 71 - 76
  • [30] A REVIEW ON KAWASAKI DISEASE
    Anitha, N.
    Husna, Adeeba
    Akbar, Syed
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (06): : 5744 - 5750